Obagi Medical Rolls Out $65 SPF 40 Mineral Sunscreen with Ceramides and Squalane
WALD•Obagi Medical launched Sun Shield™ Mineral UV Barrier Protect Broad Spectrum SPF 40, a $65 mineral sunscreen combining 100% mineral filters with ceramides, squalane and antioxidants in a lightweight, non-comedogenic formula for sensitive and post-procedure skin. The product will reach consumers via Obagi.com, Amazon and select providers, expanding Waldencast’s suncare portfolio.
1. Product Launch Details
Obagi Medical introduced Sun Shield™ Mineral UV Barrier Protect Broad Spectrum SPF 40, a mineral sunscreen formulated with 100% mineral filters, antioxidants, ceramides and squalane. The $65 lightweight, non-comedogenic formula targets sensitive, acne-prone and post-procedure skin while delivering broad-spectrum UVA/UVB protection.
2. Portfolio Evolution and Consumer Demand
This launch extends Obagi’s suncare portfolio toward mineral, skincare-first protection in response to internal data showing most U.S. sunscreen users favor mineral formulas. It leverages the brand’s medical-grade expertise to address premature aging, discoloration and barrier support within everyday regimens.
3. Distribution Channels and Revenue Potential
Sun Shield™ SPF 40 will be available on Obagi.com, Amazon and through authorized providers and select retail outlets. This multi-channel rollout is expected to strengthen Waldencast’s beauty segment revenue and enhance its position in the high-growth mineral sunscreen market.
